Effects of 5-aminolevulinic acid on cognitive functions in normal subjects using fMRI
Not Applicable
- Conditions
- healthy adults
- Registration Number
- JPRN-UMIN000009355
- Lead Sponsor
- ippon Medical School, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Subject with history of porphyria, hemochromatosis or viral hepatitis. Subject with serious disease such as renal, hepatic or cardiac disease. Subject with photosensitivity. Subject taking drug within 2 weeks of the trial. Subject with contraindications to MRI.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method